Pharmaceutical

Suven Pharmaceuticals to gain controlling stake in Sapala Organics

India-based Suven Pharmaceuticals has announced a definitive agreement to acquire a strategic controlling stake in Sapala Organics.

Jun 16, 2024 - 04:00
Suven Pharmaceuticals to gain controlling stake in Sapala Organics
India-based Suven Pharmaceuticals has announced a definitive agreement to acquire a strategic controlling stake in Sapala Organics.
Read the original article

Tags:

Previous Article

Santa Ana Bio secures $168m for inflammatory disease treatments

Next Article

AbbVie and FutureGen link on inflammatory bowel disease

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Pfizer and Novo disclose upbeat data on oral weight loss drugs; PBM trade group blasts House committee over hearing

STAT+: Pharmalittle: Pfizer and Novo disclose upbeat da...

May 23, 2023

STAT+: Bristol Myers will pay $4.1 billion for cancer startup RayzeBio

STAT+: Bristol Myers will pay $4.1 billion for cancer s...

Dec 27, 2023

GLB-001 by GluBio Therapeutics for Refractory Acute Mye...

Dec 20, 2023